Securities Fraud Class Action Lawsuit Filed Against ImmunityBio, Inc.

Kessler Topaz Meltzer & Check, LLP announced the filing of a securities fraud class action lawsuit against ImmunityBio, Inc., traded on NASDAQ under IBRX.

29 Apr, 21:42 — 29 Apr, 21:42

Post Share

Sources

Showing 1 of 1 sources

globe-and-mailHigh12h ago

NASDAQ: IBRX: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against ImmunityBio, Inc. - The Globe and Mail

NASDAQ: IBRX: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against ImmunityBio, Inc. The Globe and Mail

Read full article →

PERSPECTA

PERSPECTA

Securities Fraud Class Action Lawsuit Filed Against ImmunityBio, Inc.

Sources

NASDAQ: IBRX: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against ImmunityBio, Inc. - The Globe and Mail

Related Stories

Oil Jumps Above $100 After US-Iran Talks Fail

Pangasinan and BFAR Partner for Salt Industry Development

Philippine Senator Legarda Advocates for Proactive Climate Resilience

Philippine VP Duterte's Tax Records Under Scrutiny

PERSPECTA